药明生物根据首次公开发售前购股权计划发行405.5万股

Core Viewpoint - WuXi Biologics (02269) announced the issuance of a total of 4.055 million ordinary shares on November 10, 2025, as part of the exercise of options under its pre-IPO share option plan adopted on January 5, 2016, and revised on August 10, 2016 [1] Summary by Category - Share Issuance - The company issued 4.055 million ordinary shares as part of the option exercise [1] - Historical Context - The share option plan was initially adopted on January 5, 2016, and revised on August 10, 2016 [1] - Future Implications - The exercise of options may impact the company's capital structure and shareholder equity [1]